Multiplexed immunophenotyping of human antigen-presenting cells in whole blood by polychromatic flow cytometry

Nature Protocols

Volumn 5, Issue 2, 2010, Pages 357-370

  Fung, Erik ^a   Esposito, Laura ^a   Todd, John A ^a   Wicker, Linda S ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD123 ANTIGEN; CD1C ANTIGEN; CD209 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CX3CR1; FLUOROCHROME; HLA DR ANTIGEN; L SELECTIN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; CHEMOTAXIS; DENDRITIC CELL; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IMMUNOREGULATION; INNATE IMMUNITY; MONOCYTE; NONHUMAN; PRIORITY JOURNAL;

ANTIBODIES; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; ANTIGENS, CD11; B-LYMPHOCYTES; DENDRITIC CELLS; ERYTHROCYTES; FLOW CYTOMETRY; HLA-DR ANTIGENS; HUMANS; IMMUNOGLOBULIN ISOTYPES; IMMUNOPHENOTYPING; MONOCYTES; RECEPTORS, CCR2; RECEPTORS, INTERLEUKIN-8A;

EID: 76649125209     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2009.246     Document Type: Article

References (53)

1. Ziegler-Heitbrock, H.W.L. Definition of human blood monocytes. J. Leukoc. Biol. 67, 603-606 (2000).
2. Grage-Griebenow, E., Flad, H.D. & Ernst, M. Heterogeneity of human peripheral blood monocyte subsets. J. Leukoc. Biol. 69, 11-20 (2001).
3. Steinman, R.M. & Nussenzweig, M.C. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci. USA 99, 351-358 (2002).
4. Al-Daccak, R., Mooney, N. & Charron, D. MHC class II signaling in antigen-presenting cells. Curr. Opin. Immunol. 16, 108-113 (2004).
5. Gordon, S. & Taylor, P.R. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5, 953-964 (2005).
6. Tacke, F. et al. Immature monocytes acquire antigens from other cells in the bone marrow and present them to T cells after maturing in the periphery. J. Exp. Med. 203, 583-597 (2006).
7. Reis e Sousa, C. Dendritic cells in a mature age. Nat. Rev. Immunol. 6, 476-483 (2006).
8. Davis, M.M. A prescription for human immunology. Immunity 29, 835-838 (2008).
9. Hayday, A.C. & Peakman, M. The habitual, diverse and surmountable obstacles to human immunology research. Nat. Immunol. 9, 575-580 (2008).
10. Baumgarth, N. & Roederer, M. A practical approach to multicolor flow cytometry for immunophenotyping. J. Immunol. Methods 243, 77-97 (2000).
11. Perfetto, S.P., Chattopadhyay, P.K. & Roederer, M. Seventeen-colour flow cytometry: unravelling the immune system. Nat. Rev. Immunol. 4, 648-655 (2004).
12. Willmann, K. & Dunne, J.F. A flow cytometric immune function assay for human peripheral blood dendritic cells. J. Leukoc. Biol. 67, 536-544 (2000).
13. Seder, R.A., Darrah, P.A. & Roederer, M. T-cell quality in memory and protection: implications for vaccine design. Nat. Rev. Immunol. 8, 247-258 (2008).
14. Dendrou, C.A. et al. Gene-to-cell-specific protein phenotype for the autoimmune locus IL2RA using fresh blood from a genotype-selectable bioresource. Nat. Genet. 41, 1011-1015 (2009).
15. Tamul, K.R., Schmitz, J.L., Kane, K. & Folds, J.D. Comparison of the effects of Ficoll-Hypaque separation and whole blood lysis on results of immunophenotypic analysis of blood and bone marrow samples from patients with hematologic malignancies. Clin. Diagn. Lab Immunol. 2, 337-342 (1995).
16. Jansen, K. et al. Polychromatic flow cytometric high-throughput assay to analyze the innate immune response to Toll-like receptor stimulation. J. Immunol. Methods 336, 183-192 (2008).
17. Perfetto, S.P., Ambrozak, D., Nguyen, R., Chattopadhyay, P. & Roederer, M. Quality assurance for polychromatic flow cytometry. Nat. Protoc. 1, 1522-1530 (2006).
18. Dendrou, C.A. et al. Fluorescence intensity normalisation: correcting for time effects in large-scale flow cytometric analysis. Adv. Bioinformatics 2009 doi:10.1155/2009/476106.
19. Passlick, B., Flieger, D. & Ziegler-Heitbrock, H.W.L. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 74, 2527-2534 (1989).
20. Geissmann, F., Jung, S. & Littman, D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19, 71-82 (2003).
21. Fingerle, G. et al. The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients. Blood 82, 3170-3176 (1993).
22. Kawanaka, N. et al. CD14+,CD16+ blood monocytes and joint inflammation in rheumatoid arthritis. Arthritis. Rheum. 46, 2578-2586 (2002).
23. Belge, K.U. et al. The proinflammatory CD14+CD16+DR. monocytes are a major source of TNF. J. Immunol. 168, 3536-3542 (2002).
24. Spits, H., Couwenberg, F., Bakker, A.Q., Weijer, K. & Uittenbogaart, C.H. Id2 and Id3 inhibit development of CD34(+) stem cells into predendritic cell (pre-DC)2 but not into pre-DC1. Evidence for a lymphoid origin of pre-DC2. J. Exp. Med. 192, 1775-1784 (2000).
25. Liu, Y.J., Kanzler, H., Soumelis, V. & Gilliet, M. Dendritic cell lineage, plasticity and cross-regulation. Nat. Immunol. 2, 585-589 (2001).
26. Liu, Y.J. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 23, 275-306 (2005).
27. Münz, C., Steinman, R.M. & Fujii, S. Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity. J. Exp. Med. 202, 203-207 (2005). (Pubitemid 41043815)
28. Banchereau, J. & Pascual, V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 25, 383-392 (2006). (Pubitemid 44354221)
29. Fogg, D. et al. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 311, 83-87 (2006).
30. Dzionek, A. et al. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J. Immunol. 165, 6037-6046 (2000).
31. MacDonald, K.P. et al. Characterization of human blood dendritic cell subsets. Blood 100, 4512-4520 (2002).
32. Bonasio, R. & von Andrian, U.H. Generation, migration and function of circulating dendritic cells. Curr. Opin. Immunol. 18, 503-511 (2006).
33. Dzionek, A. et al. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J. Exp. Med. 194, 1823-1834 (2001).
34. Radbruch, A. Immunofluorescence: basic considerations. In Flow Cytometry and Cell Sorting 2nd edn 2. Chapter 3 (Springer-Verlag Berlin, Heidelberg, Germany, 2000).
35. Herzenberg, L.A., Tung, J., Moore, W.A., Herzenberg, L.A. & Parks, D.R. Interpreting flow cytometry data: a guide for the perplexed. Nat. Immunol. 7, 681-685 (2006).
36. Roederer, M. Spectral compensation for flow cytometry: visualization artefacts, limitations, and caveats. Cytometry 45, 194-205 (2001).
37. Shapiro, H.M. Parameters and probes. In Practical Flow Cytometry 4th edn. Chapter 7 (John Wiley & Sons, Inc., Hoboken, New Jersey, USA, 2003).
38. Maecker, H.T., Frey, T., Nomura, L.E. & Trotter, J. Selecting fluorochrome conjugates for maximum sensitivity. Cytometry A 62A, 169-173 (2004).
39. Maecker, H.T. & Trotter, J. Flow cytometry controls, instrument setup, and the determination of positivity. Cytometry A 69A, 1037-1042 (2006).
40. Kawai, K. et al. CD11b-mediated migratory property of peripheral blood B cells. J. Allergy Clin. Immunol. 116, 192-197 (2005).
41. Montecino-Rodriguez, E., Leathers, H. & Dorshkind, K. Identification of a B-1 B cell-specified progenitor. Nat. Immunol. 7, 293-301 (2006).
42. Arnold, L.W., Pennell, C.A., McCray, S.K. & Clarke, S.H. Development of B-1 cells: segregation of phosphatidylcholine-specific B cells to the B-1 population occurs after immunoglobulin gene expression. J. Exp. Med. 179, 1585-1595 (1994).
43. Nestle, F.O. et al. Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J. Exp. Med. 202, 135-143 (2005).
44. Summers, K.L. et al. Reduced IFN-alpha secretion by blood dendritic cells in human diabetes. Clin. Immunol. 121, 81-89 (2006).
45. Peng, R., Li, Y., Brezner, K., Litherland, S. & Clare-Salzler, M.J. Abnormal peripheral blood dendritic cell populations in type 1 diabetes. Ann. NY Acad. Sci. 1005, 222-225 (2003).
46. Allen, J.S. et al. Plasmacytoid dendritic cells are proportionally expanded at diagnosis of type 1 diabetes and enhance islet autoantigen presentation to T-cells through immune complex capture. Diabetes 58, 138-145 (2009).
47. Ochando, J.C. et al. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat. Immunol. 7, 652-662 (2006).
48. Shao, L., Jacobs, A.R., Johnson, V.V. & Mayer, L. Activation of CD8+ regulatory T cells by human placental trophoblasts. J. Immunol. 174, 7539-7547 (2005).
49. Allez, M., Brimnes, J., Dotan, I. & Mayer, L. Expansion of CD8+ T cells with regulatory function after interaction with intestinal epithelial cells. Gastroenterology 123, 1516-1526 (2002).
50. Bouloc, A., Bagot, M., Delaire, S., Bensussan, A. & Boumsell, L. Triggering CD101 molecule on human cutaneous dendritic cells inhibits T cell proliferation via IL-10 production. Eur. J. Immunol. 30, 3132-3139 (2000).
51. Ashtekar, A.R. & Saha, B. Polys plea: membership to the club of APCs. Trends Immunol. 24, 485-490 (2003).
52. Rivas, A. et al. V7, a novel leukocyte surface protein that participates in T cell activation. I. Tissue distribution and functional studies. J. Immunol. 154, 4423-4433 (1995).
53. Pyne, S. et al. Automated high-dimensional flow cytometric data analysis. Proc. Natl. Acad. Sci. USA 106, 8519-8524 (2009).